Fox Run Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-36,851
| Closed | -$893K | – | 1162 |
|
|
2025
Q2 | $893K | Sell |
36,851
-81,660
| -69% | -$1.9M | 0.15% | 228 |
|
|
2025
Q1 | $3M | Buy |
+118,511
| New | +$3.1M | 0.47% | 8 |
|
|
2024
Q4 | – | Sell |
-54,978
| Closed | -$1.59M | – | 1112 |
|
|
2024
Q3 | $1.59M | Buy |
54,978
+11,724
| +27% | +$342K | 0.35% | 21 |
|
|
2024
Q2 | $1.21M | Sell |
43,254
-22,629
| -34% | -$623K | 0.23% | 127 |
|
|
2024
Q1 | $1.83M | Buy |
+65,883
| New | +$1.83M | 0.39% | 17 |
|
|
2023
Q2 | – | Sell |
-5,139
| Closed | -$210K | – | 896 |
|
|
2023
Q1 | $210K | Buy |
+5,139
| New | +$222K | 0.07% | 521 |
|
|
2022
Q2 | – | Sell |
-7,534
| Closed | -$390K | – | 695 |
|
|
2022
Q1 | $390K | Buy |
7,534
+1,229
| +19% | +$63.8K | 0.22% | 169 |
|
|
2021
Q4 | $372K | Sell |
6,305
-1,938
| -24% | -$96K | 0.22% | 159 |
|
|
2021
Q3 | $355K | Buy |
+8,243
| New | +$365K | 0.22% | 178 |
|
|
2020
Q3 | – | Sell |
-22,510
| Closed | -$698K | – | 281 |
|
|
2020
Q2 | $698K | Buy |
+22,510
| New | +$765K | 0.92% | 2 |
|
|
2019
Q4 | – | Sell |
-25,165
| Closed | -$858K | – | 498 |
|
|
2019
Q3 | $858K | Buy |
+25,165
| New | +$915K | 0.78% | 1 |
|
|
2018
Q3 | – | Sell |
-14,515
| Closed | -$500K | – | 760 |
|
|
2018
Q2 | $500K | Sell |
14,515
-3,251
| -18% | -$111K | 0.16% | 249 |
|
|
2018
Q1 | $598K | Buy |
+17,766
| New | +$611K | 0.15% | 248 |
|
|
2017
Q4 | – | Sell |
-26,772
| Closed | -$907K | – | 833 |
|
|
2017
Q3 | $907K | Buy |
26,772
+10,013
| +60% | +$322K | 0.26% | 91 |
|
|
2017
Q2 | $534K | Buy |
+16,759
| New | +$529K | 0.18% | 199 |
|
|
2017
Q1 | – | Sell |
-19,710
| Closed | -$607K | – | 711 |
|
|
2016
Q4 | $607K | Buy |
+19,710
| New | +$602K | 0.32% | 70 |
|
|
2016
Q3 | – | Sell |
-19,815
| Closed | -$662K | – | 631 |
|
|
2016
Q2 | $662K | Buy |
+19,815
| New | +$632K | 0.32% | 58 |
|